Young Investigator Award

Young Investigator Award

The authors of the highest scoring abstracts submitted by young investigators are invited to present at the ARTERY annual meeting.


Young investigators who submitted an abstract to the ARTERY conference as presenting author can opt to compete for the ARTERY Young Investigator Award. The authors of the highest scoring abstracts will be invited to orally present their abstract at the ARTERY conference and compete for the ARTERY Young Investigator Award.


The winner of the ARTERY Young Investigator Award is awarded €500 and the winner’s name is engraved on a perpetual silver platter.

Eligibility criteria for applicants:

• Young investigators are classified by the ARTERY Society as those aged 40 years and under.
• Applicants may be from Europe or outside Europe.

Application process:

• Abstracts must be submitted via the ARTERY Conference abstract submission portal. During submission, the author can indicate whether they would like to compete for the Young Investigator Award.
• If selected, individuals must confirm that they will present their work at the conference, and register and pay for the conference according to the timeline given on the notification letter.

Previous Winners

ARTERY23 – Germany, 2023

Ryan McNally (King’s College London, United Kingdom) “Is there an antihypertensive class-specific effect on pulse wave ve-locity reduction? A systematic review and meta-analysis of the influence of blood pressure reduction on pulse wave velocity in hypertension .”

DeGAG23 – Germany, 2023

Marta Sanz-Gómez (Universidad Complutense De Madrid) “Angiotensin AT2 receptor stimulation modulates endothelial BMP-2levels by the AT2R-PP2A-AMPK pathway.”

Previous winners include: 

ARTERY22 – Nancy, 2022

Dr Keith Siew (University of Cambridge, United Kingdom) “Pentosan polysulfate, an aggrecanase inhibitor modulates arterial stiffness in spontaneously hypertensive rats.”

ARTERY21 – Paris, 2021

Alessandro Giudici (Masstricht University, The Netherlands) “Differences in systolic-diastolic distensibility indicate carotid wall viscosity in healthy controls, patients with hypertension and type 2 diabetes.”

Dimitrios Terentes-Prntzios (Hippokration Hospital, Athens) “The effect of mRNA vaccine against COVID-19 on endothelial function and arterial stiffness.”

ARTERY20 – Virtual, 2020

Sofie De Moudt (University Of Antwerp)  “Spontaneous cardiovascular ageing of C57Bl6 mice results in the development of aortic stiffness prior to peripheral blood pressure alterations.”

Daimé Campos Arias (IBiTech, Ghent University)  “Ten years of ageing in the middle-aged does not increase input impedance or wave reflection – insights from the Asklepios Study.”

 ARTERY19 – Budapest, 2019

Kenneth Fung (Queen Mary University of London) “First genome-wide association study of cardiovascular magnetic resonance derived aortic distensibility reveals 7 loci”

 ARTERY18 – Guimaraes, 2018

Rachel Climie  “Occupational, sport and leisure related physical activity have contrasting effects on neural baroreflex sensitivity”

Anish Bhuva -& Feasibility of aortic wave intensity analysis from sequentially acquired cardiac MRI and non-invasive central blood pressure”

 ARTERY17 – Copenhagen, 2017

Andrea Guala (Barcelona) “Invasive study for testing non-invasive methods of aortic pressure estimation”

 ARTERY16 – Copenhagen, 2016

Dean Picone (Hobart) “Discovery of a new blood pressure phenotype from invasive central-to-peripheral recordings: implications for brachial cuff accuracy and cardiovascular risk assessment”

 ARTERY15 – Krakow, 2015

Nanna B. Johansen (Gentofte) “The effect of glycaemic state transition on accelerated aortic stiffening: a longitudinal study in the Whitehall II cohort”

 ARTERY14 – Maastricht, 2014

Marina Cecelja (Guildford) “Gene expression analysis identify genes associated with arterial stiffness and carotid diameter in the twins UK cohort”

 ARTERY13 – London, 2013

Maureen Alivon (Paris) “Changes in blood pressure and arterial mechanical properties after antiangiogenic drugs: association with cancer progression and mortality”

 ARTERY12 – Vienna, 2012

Keith Ng (Sydney)  “Segmental aortic stiffness determined by the association of elastin degradation and calcium deposition in rat models of hypertension and aortic calcification”

 ARTERY11 – Paris, 2011

Liesbeth Taelman (Ghent) “Predicting the functional impact of residual aortic coarctation lesions during exercise using advanced computer model simulations”

ARTERY10 – Verona, 2010

Dr Natalia Lopez-Andres (Vandoeuvre-les-Nancy)  “Cardiotrophin-1 is a determinant of arterial stiffness and thickness in rodents”

ARTERY9 – Cambridge, 2009

Dr Marina Cecelja (London) “Aortic stiffness in middle aged women is heritable and relates to blood pressure and aortic calcification: a twin study”

ARTERY8 – Ghent, 2008

Roel van de Laar (Maastricht) “Life-course habitual physical activity and its impact on arterial stiffness: The Amsterdam Growth and Health Longitudinal Study (AGAHLS)”

ARTERY7 – Prague, 2007

Dr Nearchos Hadjiloizou (London)  “Can wave intensity help explain the different velocity flow profiles in the coronary arteries?”

 ARTERY6 – Athens, 2006

Dr Kaisa Maki-Petaja (Cambridge) “Ezetimibe and simvastatin both reduce inflammation, disease activity, aortic stiffness and improve endothelial function in rheumatoid arthritis”

 ARTERY5 – Paris, 2005

Anne-Isabelle Tropeano (Paris) “Humoral factors vs load: long lasting influence on arterial stiffness and thickness”